AKAP13 and fibrosis: Based on previous findings showing that AKAP13 recruits and activates the MAPK p38 [151,158] and that p38 acts as a major mediator of the profibrotic effects of Ang-II [24], one could raise the hypothesis that AKAP13 might regulate cardiac fibrosis by promoting p38 signaling in cardiac fibroblasts.